Robert Aspbury
Fortuna: 3 M $ al 31/08/2026
Fortuna: 3 M $ al 31/08/2026
Robert P.
Aspbury is President-Certara Predictive Technologies at Certara, Inc. since 2020.
Formerly, Dr. Aspbury was Vice President-Strategic Solutions at Labcorp Drug Development, Inc. from 2016 to 2019.
Dr. Aspbury earned a doctorate from The University of Liverpool in 1995.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CERTARA, INC. 0,22 % | 11/05/2026 | 332.442 ( 0,22 % ) | 3 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CERTARA, INC. | Corporate Officer/Principal | 01/01/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| COVANCE INC. | Corporate Officer/Principal | 01/03/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Certara, Inc.
Certara, Inc. Packaged SoftwareTechnology Services Develops bio simulation software and technology to transform traditional drug discovery and development | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.